Cidara Therapeutics Inc
CDTX
$63.71-1.50 (-2.31%)
Aug 18, 2025, 3:35 PM
Financials
| 52Week High | 66.95 | 52Week Low | 10.14 |
| Beta | 1.26 | Current Ratio Annual | 4.25 |
| Current Ratio Quarterly | 16.45 | Gross Margin TTM | 92.04 |
| Market Cap | 1.66B | Net Profit Margin TTM | -295.19 |
| Operating Margin TTM | -310.51 | Price To Book | 3.31 |
| Price To Free Cash Flow TTM | 54.09 | Price To Sales TTM | 42.48 |
| Quick Ratio Annual | 3.99 | Quick Ratio Quarterly | 16.05 |
| Return On Assets TTM | -42.60 | Return On Equity TTM | -50.98 |
| Return On Investment TTM | -50.92 | Revenue Growth3Y | -70.48 |
| Revenue Growth5Y | -42.85 | Revenue Per Share TTM | 0.00 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 41 | 1 | 0 | 2 | 2 | 0 | 6.87M | $183.63M |
| Mar 31, 2025 | 47(+15%) | 8(+700%) | 2(+%) | 19(+850%) | 9(+350%) | 10(+%) | 9.56M(+39%) | $205.93M(+12%) |
| Jun 30, 2025 | 110(+134%) | 70(+775%) | 7(+250%) | 29(+53%) | 6(-33%) | 3(-70%) | 27.50M(+188%) | $1.33B(+544%) |